Laurie Toich, Assistant Editor

The American Health Care Act may reduce federal debt but increase the uninsured rate.

Adding pertuzumab (Perjeta) to a breast cancer treatment regimen reduced recurrent disease.

A 2-drug combination reduced retinal cell death more effectively than a single drug therapy.

Novel treatment will be tested in patients with Parkinson’s disease who have a GBA mutation.

Padaxa reduced cardiovascular mortality by 27% compared with warfarin.

Top news of the day from across the healthcare landscape.

Under the AHCA, states would receive a lower level of federal funding for new beneficiaries.

American Health Care Act proposes significant structural changes to Medicaid.

Advocacy group warns that American Health Care Act may harm patients with diabetes.

Mylan launches desvenlafaxine extended-release tablets.

Twenty percent of patients with resistant hypertension may not take their prescribed treatments.

Drug-resistant Candida auris observed to be particularly susceptible to investigational drug.

Neoadjuvant chemotherapy decreased recurrence and increased survival in African American patients.

Myelodysplastic syndrome can lead to aggressive leukemia.

Top news of the day from across the healthcare landscape.

Antibiotics may alter the lung’s immune response in newborns.

Act 900 requires pharmacy benefit managers to reimburse generic drugs at or above costs.

Simple instant messaging-based tools such as mHealth apps can improve the uptake of healthy behaviors.

Conversational messaging tools improve healthy behavior and boost patient outcomes.

Sustained and controllable insulin delivery may improve diabetes care.

Patients with specific stem cell mutations may be at an increased risk of acute myeloid leukemia.

Protein once thought to suppress tumors in acute myeloid leukemia may instead promote the disease.

Top news of the day from across the healthcare landscape.

Kynurenic acid observed to indirectly raise glutamate levels.

Players in the pharmaceutical supply chain have come under scrutiny as legislators target high drug costs.

The complexity of the pharmaceutical supply chain is a factor inflating high drug costs.

Adjuvant bleomycin, etoposide, and cisplatin shows promise treating testicular cancer.

Many patients with stage 1 and 2 breast cancer are administered aggressive chemotherapy.

Recurrence rate was 1.3% in patients treated with 1 cycle of chemotherapy.

Patients with early-stage breast cancer may not need aggressive treatment.